ערך בספרים למניה: NeuroOne Medical Technologies Corporation (NMTC)

NeuroOne Medical Technologies (NMTC) is valued by neurosurgeons for its advanced brain sensors, although the mass production of electrodes is entirely outsourced to third-party contractors. The book value per common share indicator reflects capital dynamics, with the metric currently standing at 0.43. Stable demand in epileptology renders this business a defensive asset, ensuring predictable sales regardless of economic fluctuations.

This indicator reflects the net asset value per common share, allowing for an assessment of the business's intrinsic value and capital management efficiency. By analyzing the book value per share, an investor can track the asset accumulation of NeuroOne Medical Technologies (NMTC), which, amid stable demand for neurosurgical systems, ensures high financial stability for the company regardless of market conditions.